ARCHIVES

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

This article is from The Cancer Letter archive.

Vol. 33 No. 46 | December 14, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Little Doubt That DeVita, Frederickson Will Keep Their Jobs; New DCT Projects May Not Be Funded

March 6, 1981

NCI To Fund More Than 1,000 Competing Grants Under FY 1992 Budget

November 22, 1991

M.D. Anderson Stops Establishing Satellite Clinics, Views Role as Working With All Texas Oncologists

November 22, 1996

Hypothyroidism Associated With Reduced Breast Cancer

April 25, 2003

Managed Care: Cancer Panel Finds Need “Critical” For Cost, Outcomes Data

September 13, 1996

NCI Separates Carcinogenesis Research Efforts

February 18, 1977